While a lot of attention is focused on the efforts of pro-lifers to see the Food and Drug Administration (FDA) reimpose restrictions on the abortion pills which would stop the mailing of these pills to pro-life states, the other side continue to push to get rid of any limits on the distribution of mifepristone whatsoever.
This is what authors, many of them stalwarts in the abortion industry,[1] are challenging in this report, “Mifepristone Patient Agreement Form and Medication Abortion Knowledge: A Randomized Clinical Trial” which appeared in the October19, 2026, online edition of JAMA Internal Medicine (JAMA stands for the Journal of the American Medical Association).
Read Full Article: https://www.lifenews.com/2026/10/22/the-abortion-industry-doesnt-care-if-women-die-from-abortion-pills/
